share_log

HC Wainwright & Co. Maintains Buy on Deciphera Pharmaceuticals, Raises Price Target to $30

Benzinga ·  Oct 31, 2023 07:36

HC Wainwright & Co. analyst Andrew Fein maintains Deciphera Pharmaceuticals (NASDAQ:DCPH) with a Buy and raises the price target from $25 to $30.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment